Posts Tagged ‘phentermine’
May 2, 2022 — At the Pediatric Endocrine Society annual meeting this weekend came some good news. Pediatric obesity care providers may soon have one more option for treating teens with obesity. In a well-controlled study of Qsymia for treating obesity in teens, Aaron Kelly reported impressive results. He and his colleagues tested two doses – a mid-range and […]
March 23, 2019 — It’s great to have new options for obesity meds. Since 2010, FDA has approved four of them. But the fact is that the mainstay of obesity meds is still something that’s older than dirt – phentermine. And new data suggests that it can work safely and effectively when used as a chronic med for this […]
March 30, 2017 — A new study in Diabetes Care provides tantalizing new data on a potential new combination drug for obesity: cana/phen. The study compared a combination of 300 mg of canagliflozin and 15 mg phentermine to each drug alone and to placebo. It was a randomized, controlled study that lasted 26 weeks. The combination was more effective than […]
June 13, 2016 — Late-breaking data presented this past weekend at the Scientific Sessions of the American Diabetes Association provides a good look at the efficacy of a new combination drug treatment for obesity. The combination is 300 mg of canagliflozin (Invokana) and 15 mg of phentermine. The combination of these two drugs produced an average weight loss of 7.5% […]
May 21, 2015 — People living with obesity are finally beginning to see more options for obesity care and, in part, they can thank competition to innovate in diabetes care for some of this progress. A particularly visible example of this is liraglutide, which has been available for treating type 2 diabetes since 2009. After six years of use […]
November 8, 2014 — Some years ago, Louis Aronne predicted that combination drug therapy would be the future of obesity medicine. It’s looking more and more like he was right. An early look at another combination drug for obesity — lorcaserin + phentermine — came with the late-breaking posters on Thursday at ObesityWeek 2014. Steven Smith and colleagues presented results […]